Showing 3,861 - 3,880 results of 28,834 for search '(( 50 ((teer decrease) OR (a decrease)) ) OR ( 5 ((ng decrease) OR (nn decrease)) ))', query time: 0.91s Refine Results
  1. 3861

    X-axis shows the MEHP quartiles, and Y-axis shows each hormone level. by Atsuko Araki (641415)

    Published 2014
    “…<p>The adjusted LSMs (95% confident intervals) of each hormone level in cord blood in relation to the MEHP concentration quartile fit to all study participants are shown with <i>p</i>-value for trend, and <i>p</i> for interaction, respectively, for (<b>A</b>) T/E2 (0.017, 0.846), (<b>B</b>) P4 (0.010, 0.520), and (<b>C</b>) inhibin B (0.004, 0.042). First quartile (≦5.90 ng/mL) is also compared to the 2nd (5.91–10.39 ng/mL), 3rd (10.40–15.30 ng/mL) and 4th (15.31+ ng/mL) quartile MEHP. …”
  2. 3862

    Binding of <i>PC3/Tis21</i> to the <i>Id3</i> promoter and corresponding decrease of <i>Id3</i> mRNA. by Stefano Farioli-Vecchioli (256006)

    Published 2009
    “…The <i>Id3</i> promoter construct comprised 1592 nt 5′ to the putative transcription start, placed upstream of a luciferase reporter (construct pGL3-<i>Id3</i>-prom/-1592). …”
  3. 3863
  4. 3864
  5. 3865

    Optic nerve head degeneration and decrease in RGCs observed in <i>Vav2<sup>−/−</sup>Vav3<sup>−/−</sup></i> mice with elevated IOP. by Keiko Fujikawa (253775)

    Published 2010
    “…In those retinas, RGCs are decreased. Scale bars, from left to right side: 500 µm, 100 µm, and 50 µm. …”
  6. 3866
  7. 3867
  8. 3868
  9. 3869
  10. 3870
  11. 3871
  12. 3872
  13. 3873
  14. 3874
  15. 3875
  16. 3876
  17. 3877
  18. 3878

    Expression and distribution of p-JNK and JNK proteins in the P7 rat brain after HI as detected by Western blot analysis and fluorescence immunolabeling. by Deyuan Li (769599)

    Published 2015
    “…Total JNK protein was not obviously changed at different time points compared with sham controls (A). However, p-JNK protein levels transiently decreased at 0.5 h, increased at 6 and 24 h, peaked at 48 h, and lasted until 72 h (A). …”
  19. 3879
  20. 3880

    Effects of Pitavastatin on Lipid Profiles in HIV-Infected Patients with Dyslipidemia and Receiving Atazanavir/Ritonavir: A Randomized, Double-Blind, Crossover Study by Asita Wongprikorn (2837378)

    Published 2016
    “…<div><p>Background</p><p>Dyslipidemia as a risk factor of cardiovascular disease is common especially in HIV-infected patients who are using protease inhibitors (PIs) including atazanavir. …”